Polar Capital Holdings’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Polar Capital Holdings’s Portfolio MRTX Stock Details MRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-29,390	Closed	-$1.97K	–	454
2022 Q2	$1.97K	Hold	29,390	–	–	0.01%	279
2022 Q1	$2.42K	Buy	29,390 +2,728	+10%	+$279K	0.01%	300
2021 Q4	$3.91K	Sell	26,662 -33,930	-56%	-$5.27M	0.01%	271
2021 Q3	$10.7K	Buy	60,592 +1,619	+3%	+$260K	0.04%	224
2021 Q2	$9.53K	Buy	58,973 +18,973	+47%	+$3.05M	0.04%	230
2021 Q1	$6.85M	Sell	40,000 -10,000	-20%	-$1.98M	0.04%	235
2020 Q4	$11M	Buy	+50,000	New	+$10.8M	0.07%	206

Other funds holding MRTX

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Polar Capital Holdings's MRTX Position: Q3 2022 in Review

Polar Capital Holdings sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q3 2022, closing a stake of 29,390 shares — an estimated $1.97K sold.

Polar Capital Holdings first reported a position in MRTX in Q4 2020 and held it in 7 quarters. The position peaked at $11M in Q4 2020. 243 funds tracked by Wall St. Rank hold MRTX as of Q3 2022.

Polar Capital Holdings reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Polar Capital Holdings sold 29,390 Mirati Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $1.97K.
Polar Capital Holdings first reported a position in Mirati Therapeutics, Inc. Common Stock in Q4 2020 and held it in 7 quarters.
Polar Capital Holdings's Mirati Therapeutics, Inc. Common Stock position peaked at $11M in Q4 2020.
243 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Polar Capital Holdings's 13F filing for Q3 2022, filed 14 Nov 2022.